BMS-795311 is utilized in medical research to study the inhibition of the PDE4 enzyme, which is involved in inflammatory processes in the body. This research focuses on developing new drugs for treating inflammation-related diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and rheumatoid arthritis. Additionally, studies evaluate its potential in treating neurological disorders, including Alzheimer's disease and Parkinson's disease, as PDE4 plays a key role in brain processes and neuronal cell function. Preliminary research indicates that BMS-795311 may help reduce inflammation and improve nervous system function. However, further studies are required to confirm its efficacy and safety before clinical application.